Identification of a hotspot on PD-L1 for pH-dependent binding by monoclonal antibodies for tumor therapy

Ähnliche Einträge

• Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapy
  von: Liu, Hongchuan, et al.
  Veröffentlicht: (2019)
• The FG Loop of PD-1 Serves as a “Hotspot” for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy
  von: Chen, Danqing, et al.
  Veröffentlicht: (2019)
• Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab
  von: Tan, Shuguang, et al.
  Veröffentlicht: (2017)
• The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
  von: Shi, Rui, et al.
  Veröffentlicht: (2020)
• Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy
  von: Liu, Kefang, et al.
  Veröffentlicht: (2017)